BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15506544)

  • 1. Ibuprofen and Alzheimer's disease.
    Dokmeci D
    Folia Med (Plovdiv); 2004; 46(2):5-10. PubMed ID: 15506544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.
    Lim GP; Yang F; Chu T; Chen P; Beech W; Teter B; Tran T; Ubeda O; Ashe KH; Frautschy SA; Cole GM
    J Neurosci; 2000 Aug; 20(15):5709-14. PubMed ID: 10908610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.
    Blasko I; Apochal A; Boeck G; Hartmann T; Grubeck-Loebenstein B; Ransmayr G
    Neurobiol Dis; 2001 Dec; 8(6):1094-101. PubMed ID: 11741404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
    Pasinetti GM
    J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
    Townsend KP; Praticò D
    FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.
    Morihara T; Teter B; Yang F; Lim GP; Boudinot S; Boudinot FD; Frautschy SA; Cole GM
    Neuropsychopharmacology; 2005 Jun; 30(6):1111-20. PubMed ID: 15688088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory treatment in AD mice protects against neuronal pathology.
    Choi JK; Jenkins BG; Carreras I; Kaymakcalan S; Cormier K; Kowall NW; Dedeoglu A
    Exp Neurol; 2010 Jun; 223(2):377-84. PubMed ID: 19679126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery, mechanisms of action and safety of ibuprofen.
    Rainsford KD
    Int J Clin Pract Suppl; 2003 Apr; (135):3-8. PubMed ID: 12723739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
    Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
    Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.
    Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G
    J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease.
    Wilkinson BL; Cramer PE; Varvel NH; Reed-Geaghan E; Jiang Q; Szabo A; Herrup K; Lamb BT; Landreth GE
    Neurobiol Aging; 2012 Jan; 33(1):197.e21-32. PubMed ID: 20696495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation into the neuroprotective properties of ibuprofen.
    Lambat Z; Conrad N; Anoopkumar-Dukie S; Walker RB; Daya S
    Metab Brain Dis; 2000 Dec; 15(4):249-56. PubMed ID: 11383549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal NSAIDs for Alzheimer's Disease.
    Lehrer S
    Am J Alzheimers Dis Other Demen; 2014 Aug; 29(5):401-3. PubMed ID: 24413537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
    Gasparini L; Ongini E; Wenk G
    J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen treatment modifies cortical sources of EEG rhythms in mild Alzheimer's disease.
    Babiloni C; Frisoni GB; Del Percio C; Zanetti O; Bonomini C; Cassetta E; Pasqualetti P; Miniussi C; De Rosas M; Valenzano A; Cibelli G; Eusebi F; Rossini PM
    Clin Neurophysiol; 2009 Apr; 120(4):709-18. PubMed ID: 19324592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity.
    Klegeris A; McGeer PL
    Neurobiol Aging; 2002; 23(5):787-94. PubMed ID: 12392782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
    Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
    Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease.
    Zhang J; Sui J; Ching CB; Chen WN
    Proteomics; 2008 Apr; 8(8):1595-607. PubMed ID: 18351690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
    Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease.
    Imbimbo BP
    Expert Opin Investig Drugs; 2004 Nov; 13(11):1469-81. PubMed ID: 15500394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.